Cargando...
Pilot Study of Oral Valganciclovir Therapy in Patients With Classic Kaposi Sarcoma
We conducted a clinical trial of oral valganciclovir, a drug with in vitro activity against Kaposi sarcoma (KS)–associated herpesvirus (KSHV), in classic KS. Five human immunodeficiency virus–seronegative participants received valganciclovir for up to six 4-week cycles at doses used for cytomegalovi...
Gardado en:
| Publicado en: | J Infect Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2011
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6767870/ https://ncbi.nlm.nih.gov/pubmed/21450998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiq177 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|